The capacity of Staphylococcus aureus to express resistance to multiple antibiotics is a major global health problem. The recent emergence of strains with decreased susceptibility to vancomycin (VISA isolates) is particularly worrisome. New and effective antimicrobials against S. aureus are therefore needed. Recent attention has been paid to antimicrobial peptides (APs) as possible therapeutic agents in combating the problem of antibiotic-resistant strains of bacteria. Our research program and the studies of others have implicated human lysosomal cathepsin G (cat G) as a potent mediator of neutrophil killing of S. aureus. We have discovered an AP within the full-length cat G sequence that has potent in vitro activity against S. aureus (including VISA isolates and methicillin-resistant strains); this peptide comprises residues 117-136 of cat G and is termed CG 117-136. During the past funding period we successfully modified CG 117-136 to enhance its bactericidal activity. We also found that levels of staphylococcal susceptibility to CG 117-136 were linked to the major cold shock gone cspA. Loss of cspA expression due to Tn551insertional mutagenesis or deletion resulted in decreased susceptibility of S. aureus to this peptide. These cspA mutations also resulted in decreased or increased expression of several proteins and loss of pigmentation production. Moreover, growth of S. aureus in the presence of a sublethal concentration of this AP impacted the expression of several genes. In this proposal we will use a combination of microbial genetic (mutant selection), biochemical (proteomic analysis) and molecular (microarray gene chip technology) techniques to extend these observations with the goal of defining how S. aureus responds to AP. We will first define the role of cold shock gene expression in determining levels of AP susceptibility and pigment production (Specific Aim 1). The mechanisms by which cold shock proteins (CSPs) regulate S. aureus genes will be determined (Specific Aim 2). As exposure to AP represents a stress situation for bacteria, we will examine the genomic response of S. aureus to CG 117-136 by determining the genes of S. aureus that are regulated at the level of transcription during exposure to APs (Specific Aim 3). The integration of the genetic, molecular and biochemical experiments proposed will advance our knowledge regarding the mechanism of AP-killing of S. aureus and how this pathogen may develop resistance to this activity. This information should help in the development of new effective peptide-based drugs that could be used in the future to combat staphylococcal diseases caused by antibiotic-resistant strains.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI043316-05A1
Application #
6771423
Study Section
Special Emphasis Panel (ZRG1-IDM-E (03))
Program Officer
Peters, Kent
Project Start
1998-07-15
Project End
2009-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
5
Fiscal Year
2004
Total Cost
$193,650
Indirect Cost
Name
Emory University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Duval, Brea D; Mathew, Anselmo; Satola, Sarah W et al. (2010) Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB. Antimicrob Agents Chemother 54:2283-90
Katzif, Samuel; Lee, Eun-Hee; Law, Anthony B et al. (2005) CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism. J Bacteriol 187:8181-4
Zughaier, Susu M; Shafer, William M; Stephens, David S (2005) Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 7:1251-62
Rivera-Marrero, Carlos A; Stewart, Julie; Shafer, William M et al. (2004) The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli. Infect Immun 72:5712-21
Sieprawska-Lupa, Magdalena; Mydel, Piotr; Krawczyk, Katarzyna et al. (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-9
Katzif, Samuel; Danavall, Damien; Bowers, Samera et al. (2003) The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G. Infect Immun 71:4304-12
Mak, Pawel; Pohl, Jan; Dubin, Adam et al. (2003) The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int J Antimicrob Agents 21:13-9
Shafer, W M; Katzif, S; Bowers, S et al. (2002) Tailoring an antibacterial peptide of human lysosomal cathepsin G to enhance its broad-spectrum action against antibiotic-resistant bacterial pathogens. Curr Pharm Des 8:695-702
Fallon, M T; Shafer, W; Jacob, E (1999) Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats. J Surg Res 86:97-102